|Therapeutic Class:||Thiazolidinedione Group|
|Manufacturer:||Unimed Unihealth MFG. Ltd.|
|Last Updated:||2020-11-19 18:15:00|
Actose Tablet contains Pioglitazone. Actose uses:
Actose Tablet is indicated as an adjunct to diet and exercise to improve glycaemic control in patients with type II diabetes (NIDDM). Actose Tablet is indicated for monotherapy and also indicated for use in combination with sulphonylurea, Metformin or Insulin when diet and exercise plus the single agent does not result in adequate glycaemic control.
Actose Tablet contains Pioglitazone 15 mg. Actose doses:
Actose Tablet can be taken once daily without regard to meals. The management of antidiabetic therapy should be individualized. Actose Tablet monotherapy may be initiated at 15 mg or 30 mg once daily dosages in patients not adequately controlled with diet and exercise alone. For patients who respond inadequately to the initial dose of Actose Tablet, the dose can be increased up to 45 mg once daily. For patients not responding adequately to monotherapy, combination therapy should be considered.
Maximum recommended daily dose of Actose Tablet should not exceed 45 mg since doses higher than 45 mg have not been studied in placebo controlled clinical studies. Besides, no placebo controlled clinical studies of more than 30 mg once daily have been conducted in combination therapy.
The overall incidence and types of adverse events reported in placebo controlled clinical trials of Actose Tablet monotherapy at doses of 7.5 mg, 15 mg, 30 mg or 45 mg once daily are upper respiratory tract infection (13.2%), headache (9.1%), sinusitis (6.3%), myalgia (5.4%), tooth disorder (5.3%), and pharyngitis (5.1%).
Actose Tablet is a preparation of Actose Tablet which is a member of the newest class of oral antidiabetic agent called thiazolidinediones. It depends on the presence of Insulin for its mechanism of action. Actose Tablet decreases Insulin resistance in the periphery and in the liver, resulting in increased Insulin dependent glucose disposal and decreased hepatic glucose output. It also improves abnormality in lipid metabolism by activating peroxisome proliferator activated receptor gamma (PPAR-γ).
Actose Tablet exerts its antihyperglycaemic effect only in the presence of Insulin. Therefore, it should not be used in Type 1 diabetes or for the treatment of diabetic ketoacidosis. Actose Tablet should be used with caution in case of combination antidiabetic therapy and hepatic insufficiency. Liver enzyme should be monitored regularly.
Administration of thiazolidinediones with an oral contraceptive containing ethinyl oestradiol and norethindrone reduces the plasma concentration of both hormones by approximately 30% which could result in loss of contraception.
Pregnancy: There are no adequate and well controlled studies in pregnant women. Actose Tablet should be used during pregnancy only if the potential benefit justifies the potential risk to the foetus.
Lactation: It is not known whether Actose Tablet is secreted in human milk. As many drugs are excreted in human milk, it should not be administered to a lactating women.
Actose Tablet is contraindicated in patients with known hypersensitivity to any of its components.
Store at 25° C.
Actose Tablet price in Bangladesh 11.20